Back
Verizon Communications, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
35
VZ
Verizon Communications, Inc.
Last Price:
$39.92
Seasonality Move:
0.9%
Sell
46
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$112.98
Seasonality Move:
-13.08%
Sell
35
Verizon Communications, Inc. (VZ)
is a Sell
Is Verizon Communications, Inc. a Buy, Sell or Hold?
-
The current Verizon Communications, Inc. [VZ] share price is $39.82. The Score for VZ is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
VZ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $112.14. The Score for RYTM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VZ Stock Price Chart
What is Verizon Communications, Inc.'s stock price today?
-
The Verizon Communications, Inc. share price today is $39.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VZ is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $112.14Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
VZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.57 | Buy |
| Relative Strength Index (14 RSI): | 41.79 | Sell |
| Chaikin Money Flow: | -50834711 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.32 - 41.24) | Sell |
| Bollinger Bands (100): | (40.16 - 43.7) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 21.04 | Buy |
| Relative Strength Index (14 RSI): | 57.33 | Buy |
| Chaikin Money Flow: | -397876 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.55 - 111.41) | Buy |
| Bollinger Bands (100): | (95.71 - 108.65) | Buy |
VZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.46 | Sell |
| 20-day SMA: | 40.71 | Sell |
| 50-day SMA: | 40.35 | Sell |
| 200-day SMA: | 42.6 | Sell |
| 8-day EMA: | 21.33 | Buy |
| 20-day EMA: | 10.46 | Buy |
| 50-day EMA: | 4.56 | Buy |
| 200-day EMA: | 1.19 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 112.08 | Buy |
| 20-day SMA: | 107.87 | Buy |
| 50-day SMA: | 106.41 | Buy |
| 200-day SMA: | 83.22 | Buy |
| 8-day EMA: | 59.27 | Buy |
| 20-day EMA: | 29.03 | Buy |
| 50-day EMA: | 12.66 | Buy |
| 200-day EMA: | 3.31 | Buy |
Verizon Communications, Inc. Earnings Growth & VZ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.11 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.
Verizon Communications, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||